These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3622948

  • 1. Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate.
    Konturek SJ, Radecki T, Piastucki I, Drozdowicz D.
    Digestion; 1987; 37 Suppl 2():8-15. PubMed ID: 3622948
    [Abstract] [Full Text] [Related]

  • 2. Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.
    Konturek SJ, Radecki T, Piastucki I, Brzozowski T, Drozdowicz D.
    Gut; 1987 Feb; 28(2):201-5. PubMed ID: 3470240
    [Abstract] [Full Text] [Related]

  • 3. Advances in the understanding of the mechanism of cytoprotective action by colloidal bismuth subcitrate.
    Konturek SJ, Radecki T, Piastucki I, Drozdowicz D.
    Scand J Gastroenterol Suppl; 1986 Feb; 122():6-10. PubMed ID: 3465028
    [Abstract] [Full Text] [Related]

  • 4. Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats.
    Konturek SJ, Dembinski A, Warzecha Z, Bielanski W, Brzozowski T, Drozdowicz D.
    Gut; 1988 Jul; 29(7):894-902. PubMed ID: 3260885
    [Abstract] [Full Text] [Related]

  • 5. Gastric mucosa protective effects of colloidal bismuth subcitrate (DE-NOL).
    Hall DW, van den Hoven WE.
    Int J Tissue React; 1987 Jul; 9(5):427-32. PubMed ID: 3478321
    [Abstract] [Full Text] [Related]

  • 6. Gastric mucosa protection and prostaglandin E2 generation in rats by colloidal bismuth subcitrate (DE-NOL).
    Hall DW, van den Hoven WE.
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):308-19. PubMed ID: 3473983
    [Abstract] [Full Text] [Related]

  • 7. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN, Nio CY.
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [Abstract] [Full Text] [Related]

  • 8. Fibroblast growth factor in gastroprotection and ulcer healing: interaction with sucralfate.
    Konturek SJ, Brzozowski T, Majka J, Szlachcic A, Bielanski W, Stachura J, Otto W.
    Gut; 1993 Jul; 34(7):881-7. PubMed ID: 8344573
    [Abstract] [Full Text] [Related]

  • 9. Cytoprotective and ulcer healing properties of prostaglandin E2, colloidal bismuth and sucralfate in rats.
    Konturek SJ, Stachura J, Radecki T, Drozdowicz D, Brzozowski T.
    Digestion; 1987 Jul; 38(2):103-13. PubMed ID: 3126091
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide in gastroprotective and ulcer healing effects of sucralfate.
    Konturek SJ, Brzozowski T, Pytko-Polonczyk J.
    Scand J Gastroenterol Suppl; 1995 Jul; 210():22-7. PubMed ID: 8578200
    [Abstract] [Full Text] [Related]

  • 11. [Protective effect of colloidal bismuth subcitrate on gastric mucosal lesion induced by aspirin].
    Chen SP, Chen J, Wen SH.
    Zhonghua Nei Ke Za Zhi; 1990 May; 29(5):293-5, 318. PubMed ID: 2242692
    [Abstract] [Full Text] [Related]

  • 12. Mucosal ulcerogenic action of monochloramine in rat stomachs: effects of polaprezinc and sucralfate.
    Kato S, Nishiwaki H, Konaka A, Takeuchi K.
    Dig Dis Sci; 1997 Oct; 42(10):2156-63. PubMed ID: 9365151
    [Abstract] [Full Text] [Related]

  • 13. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G, Parente F.
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [Abstract] [Full Text] [Related]

  • 14. SU-840, a novel synthetic flavonoid derivative of sophoradin, with potent gastroprotective and ulcer healing activity.
    Brzozowski T, Konturek SJ, Kwiecien S, Pajdo R, Drozdowicz D, Sliwowski Z, Muramatsu M.
    J Physiol Pharmacol; 1998 Mar; 49(1):83-98. PubMed ID: 9594413
    [Abstract] [Full Text] [Related]

  • 15. Colloidal bismuth subcitrate in peptic ulcer--a review.
    Tytgat GN.
    Digestion; 1987 Mar; 37 Suppl 2():31-41. PubMed ID: 3305117
    [Abstract] [Full Text] [Related]

  • 16. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B.
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11 Suppl 1():113-6. PubMed ID: 2657280
    [Abstract] [Full Text] [Related]

  • 17. Healing of chronic antral gastritis: effect of sucralfate and colloidal bismuth subcitrate.
    Kumar M, Yachha SK, Aggarwal R, Shukla S, Pandey R, Prasad KN, Ayyagari A, Naik SR.
    Indian J Gastroenterol; 1996 Jul; 15(3):90-3. PubMed ID: 8840633
    [Abstract] [Full Text] [Related]

  • 18. [De-nol in NSAID-induced gastroduodenal lesions].
    Cataldo MG, D'Aiuto A, Bongiorno A.
    Minerva Dietol Gastroenterol; 1990 Jul; 36(1):27-30. PubMed ID: 2186304
    [Abstract] [Full Text] [Related]

  • 19. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W.
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [Abstract] [Full Text] [Related]

  • 20. Protective properties of colloidal bismuth subcitrate on gastric mucosa.
    Hall DW, van den Hoven WE.
    Scand J Gastroenterol Suppl; 1986 Sep; 122():11-3. PubMed ID: 3465026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.